Back to Search
Start Over
Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma
- Source :
- Leukemia; June 2017, Vol. 31 Issue: 6 p1446-1449, 4p
- Publication Year :
- 2017
Details
- Language :
- English
- ISSN :
- 08876924 and 14765551
- Volume :
- 31
- Issue :
- 6
- Database :
- Supplemental Index
- Journal :
- Leukemia
- Publication Type :
- Periodical
- Accession number :
- ejs42846524
- Full Text :
- https://doi.org/10.1038/leu.2017.58